DE60332609D1 - Nachweis von glucose in lösungen, die auch alpha-hydroxysäure oder ein beta-diketon enthalten - Google Patents

Nachweis von glucose in lösungen, die auch alpha-hydroxysäure oder ein beta-diketon enthalten

Info

Publication number
DE60332609D1
DE60332609D1 DE60332609T DE60332609T DE60332609D1 DE 60332609 D1 DE60332609 D1 DE 60332609D1 DE 60332609 T DE60332609 T DE 60332609T DE 60332609 T DE60332609 T DE 60332609T DE 60332609 D1 DE60332609 D1 DE 60332609D1
Authority
DE
Germany
Prior art keywords
dietetone
glucose
beta
determination
solutions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60332609T
Other languages
German (de)
English (en)
Inventor
George Y Daniloff
Aristotle G Kalivretenos
Alexandre V Nikolaitchik
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sensors for Medecine and Science Inc
Original Assignee
Sensors for Medecine and Science Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US10/187,903 external-priority patent/US6800451B2/en
Application filed by Sensors for Medecine and Science Inc filed Critical Sensors for Medecine and Science Inc
Application granted granted Critical
Publication of DE60332609D1 publication Critical patent/DE60332609D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

DE60332609T 2002-03-14 2003-03-14 Nachweis von glucose in lösungen, die auch alpha-hydroxysäure oder ein beta-diketon enthalten Expired - Lifetime DE60332609D1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US36388502P 2002-03-14 2002-03-14
US10/187,903 US6800451B2 (en) 2001-01-05 2002-07-03 Detection of glucose in solutions also containing an alpha-hydroxy acid or a beta-diketone
PCT/US2003/007938 WO2003078424A1 (en) 2002-03-14 2003-03-14 Detection of glucose in solutions also containing an alpha-hydroxy acid or a beta-diketone

Publications (1)

Publication Number Publication Date
DE60332609D1 true DE60332609D1 (de) 2010-07-01

Family

ID=36936437

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60332609T Expired - Lifetime DE60332609D1 (de) 2002-03-14 2003-03-14 Nachweis von glucose in lösungen, die auch alpha-hydroxysäure oder ein beta-diketon enthalten

Country Status (8)

Country Link
CN (1) CN100549009C (es)
AT (1) ATE468335T1 (es)
DE (1) DE60332609D1 (es)
DK (1) DK1490359T3 (es)
ES (1) ES2345194T3 (es)
HK (1) HK1071130A1 (es)
PT (1) PT1490359E (es)
SI (1) SI1490359T1 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114478597B (zh) * 2021-12-29 2023-08-29 宁波大学 一种快速识别葡萄糖手性的试剂及其制备方法和应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2284809B (en) * 1993-11-07 1998-04-29 Japan Res Dev Corp A fluorescent phenylboronic acid suitable for use in the detection of saccharides
CA2322858C (en) * 1998-03-11 2009-06-02 Sensors For Medicine And Science, Inc. Detection of analytes by fluorescent lanthanide chelates

Also Published As

Publication number Publication date
ES2345194T3 (es) 2010-09-17
SI1490359T1 (sl) 2010-09-30
PT1490359E (pt) 2010-07-09
DK1490359T3 (da) 2010-06-14
HK1071130A1 (en) 2005-07-08
CN100549009C (zh) 2009-10-14
CN1826337A (zh) 2006-08-30
ATE468335T1 (de) 2010-06-15

Similar Documents

Publication Publication Date Title
IS2919B (is) Samsetning og andveiruvirkni umskiptra azaindóloxóediksýrupíperazínafleiðna
NO20011174D0 (no) Nye heteroaromatiske inhibitorer av fruktose-1,6-bisfosfotase
BR0109062A (pt) Inibidores de frutose-1,6-bisfosfatase de arila
AU2003247375A8 (en) Nucleic acid sequencing by signal stretching and data integration
ES2056854T3 (es) Tiadiazinonas.
DE60308431D1 (de) Geschäumte Säurebehandlungsflüssigkeit
DE3870560D1 (de) Zusammensetzung, geeignet zur verwendung als oder in sauren klarspuelmitteln.
HK1087697A1 (en) Novel diphenyl azetidinone with improved physiological characteristics, corresponding production method, medicaments containing said compound and use of the latter
DK1617834T3 (da) Anvendelse af en farmaceutisk sammensætning indeholdende mælkesyre eller lactat og kalium til behandling af hjerneödem eller hjerneskade
NO20050134D0 (no) Difenylazetidioner substituert med syregrupper, fremgangsmate for fremstilling av disse, medikamenter inneholdende disse forbindelser og deres anvendelse
DE50300979D1 (de) Verwendung von Makromonomeren für die Herstellung von Acrylathaftklebemassen
DE602005012535D1 (de) Aus teilen bestehendes kit für die durchführung einer antitumorbehandlung oder antiviralen behandlung in einem säugetier
DE60309719D1 (de) N-substituierte-1h-indol-5-propansäure verbindungen als ppar-agonisten zur behandlung von diabetis
AU2003228806A8 (en) Nucleic acid reactions using labels with different redox potentials
FR2883184B1 (fr) Composition de spirulines riche en principes actifs, procede d'obtention et utilisation
DE60332609D1 (de) Nachweis von glucose in lösungen, die auch alpha-hydroxysäure oder ein beta-diketon enthalten
WO2005077397A3 (en) Methods and compositions for treating vascular diseases
IT1312060B1 (it) Uso dell'acido alfa lipoico nel trattamento antimetastatico.
ATE345797T1 (de) Substituierte imidazolidine, verfahren zu ihrer herstellung, ihre verwendung als medikament oder diagnostikum sowie enthaltendes medikament
RU2003117263A (ru) Способ прогнозирования эффективности терапии у больных лепрой
DE60215226D1 (de) Methode für die isolierung von dna
SE0400522D0 (sv) A medical solution, a method for producing said medical solution and use thereof
GB0419012D0 (en) Estimation of activity or inhibition of processes involved in nucleic acid modification using chemiluminescent quenching
ITMC20020034A1 (it) Procedimento per la realizzazione di manufatti laminati in argento o altri metalli preziosi.
ITRM20030442A0 (it) Composizione farmaceutica (stressen) per il trattamento di iperomocisteinemia.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition